• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核黄素-紫外线A光诱导角膜胶原交联治疗圆锥角膜的辅助手术疗法:意大利一项研究的初步屈光结果

Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study.

作者信息

Caporossi Aldo, Baiocchi Stefano, Mazzotta Cosimo, Traversi Claudio, Caporossi Tomaso

机构信息

Department of Ophthalmological and Neurosurgical Sciences, Siena University, Siena, Italy.

出版信息

J Cataract Refract Surg. 2006 May;32(5):837-45. doi: 10.1016/j.jcrs.2006.01.091.

DOI:10.1016/j.jcrs.2006.01.091
PMID:16765803
Abstract

PURPOSE

To assess the effectiveness of riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen in reducing progression of keratoconus and in improving visual acuity in patients with progressive keratoconus.

SETTING

Department of Ophthalmology, Siena University, Siena, Italy.

METHODS

This was a second-phase prospective nonrandomized open study. Starting in September 2004, 10 eyes of 10 patients (mean age 31.4 years) with bilateral keratoconus were treated by combined riboflavin-ultraviolet type A rays (UVA) collagen cross-linking. Radiant energy was 3 mW/cm2 or 5.4 joule/cm2 for a 30-minute exposure at 1 cm from the corneal apex. A complete ophthalmologic examination (uncorrected visual acuity [UCVA], sphere spectacles corrected visual acuity (SSCVA), best spectacle-corrected visual acuity [BSCVA]) was performed. Patients had corneal computerized topographic examination, linear scan optical tomography, endothelial cell count, ultrasound pachometry, intraocular pressure (IOP) evaluation, and HRT II system confocal microscopy at 1, 2, 3, and 6 months. After treatment, eyes were medicated and dressed with a soft contact lens.

RESULTS

Comparative preoperative and postoperative results showed increases of 3.6 lines for UCVA (P = .0000112), 1.85 lines for SSCVA (P = .00065), and 1.66 lines for BSCVA (P = .00071). Topographic analysis showed a mean K reduction of 2.1 +/- 0.13 diopters (D) in the central 3.0 mm. Statistical analysis of IOP and endothelial cell count did not show significant differences. Topo-aberrometric analysis findings of corneal symmetry showed a trend toward increasing corneal symmetry with a major reduction in asymmetry between vertical hemimeridians.

CONCLUSIONS

Refractive results showed a reduction of about 2.5 D in the mean spherical equivalent, topographically confirmed by the reduction in mean K. Results of surface aberrometric analysis showed improvement in morphologic symmetry with a significant reduction in comatic aberrations.

摘要

目的

评估核黄素 - A型紫外线诱导角膜胶原交联在减缓圆锥角膜进展及提高进行性圆锥角膜患者视力方面的有效性。

地点

意大利锡耶纳锡耶纳大学眼科。

方法

这是一项二期前瞻性非随机开放研究。从2004年9月开始,对10例双侧圆锥角膜患者(平均年龄31.4岁)的10只眼睛进行核黄素 - A型紫外线(UVA)联合胶原交联治疗。在距离角膜顶点1 cm处进行30分钟的照射,辐射能量为3 mW/cm²或5.4焦耳/cm²。进行了全面的眼科检查(未矫正视力[UCVA]、球镜矫正视力[SSCVA]、最佳眼镜矫正视力[BSCVA])。患者在1、2、3和6个月时进行角膜计算机化地形图检查、线性扫描光学断层扫描、内皮细胞计数、超声角膜测厚、眼压(IOP)评估以及HRT II系统共焦显微镜检查。治疗后,眼睛用药并佩戴软性接触镜。

结果

术前与术后结果对比显示,UCVA提高了3.6行(P = .0000112),SSCVA提高了1.85行(P = .00065),BSCVA提高了1.66行(P = .00071)。地形图分析显示,中央3.0 mm区域平均角膜曲率(K)降低了2.1±0.13屈光度(D)。眼压和内皮细胞计数的统计分析未显示出显著差异。角膜对称性的地形图像差分析结果显示,角膜对称性有增加的趋势,垂直半子午线之间的不对称性明显降低。

结论

屈光结果显示平均球镜等效度降低约2.5 D,地形图检查通过平均角膜曲率的降低得到证实。表面像差分析结果显示形态对称性有所改善,彗差显著降低。

相似文献

1
Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study.核黄素-紫外线A光诱导角膜胶原交联治疗圆锥角膜的辅助手术疗法:意大利一项研究的初步屈光结果
J Cataract Refract Surg. 2006 May;32(5):837-45. doi: 10.1016/j.jcrs.2006.01.091.
2
Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study.意大利角膜交联治疗圆锥角膜的长期疗效:锡耶纳眼交叉研究。
Am J Ophthalmol. 2010 Apr;149(4):585-93. doi: 10.1016/j.ajo.2009.10.021. Epub 2010 Feb 6.
3
Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking.对接受角膜交联术的圆锥角膜眼进行屈光、地形图、断层扫描和像差分析。
Ophthalmology. 2009 Mar;116(3):369-78. doi: 10.1016/j.ophtha.2008.09.048. Epub 2009 Jan 22.
4
Morphological and functional correlations in riboflavin UV A corneal collagen cross-linking for keratoconus.核黄素 UVA 角膜胶原交联术治疗圆锥角膜的形态与功能相关性。
Acta Ophthalmol. 2012 May;90(3):259-65. doi: 10.1111/j.1755-3768.2010.01890.x. Epub 2010 Apr 23.
5
Corneal crosslinking with riboflavin and UVA for the treatment of keratoconus.核黄素和紫外线A角膜交联术治疗圆锥角膜
J Cataract Refract Surg. 2007 Jul;33(7):1143-4; author reply 1144. doi: 10.1016/j.jcrs.2007.03.056.
6
Comparison of sequential vs same-day simultaneous collagen cross-linking and topography-guided PRK for treatment of keratoconus.序贯式与同日同步胶原交联联合地形图引导的准分子激光原位角膜磨镶术治疗圆锥角膜的比较
J Refract Surg. 2009 Sep;25(9):S812-8. doi: 10.3928/1081597X-20090813-10. Epub 2009 Sep 11.
7
Two-year corneal cross-linking results in patients younger than 18 years with documented progressive keratoconus.18 岁以下有明确进展性圆锥角膜病史患者的两年角膜交联结果。
Am J Ophthalmol. 2012 Sep;154(3):520-6. doi: 10.1016/j.ajo.2012.03.020. Epub 2012 May 24.
8
A randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus: three-year results.一项角膜胶原交联术治疗进行性圆锥角膜的随机对照临床试验:三年结果。
Ophthalmology. 2014 Apr;121(4):812-21. doi: 10.1016/j.ophtha.2013.10.028. Epub 2014 Jan 6.
9
Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: ultrastructural analysis by Heidelberg Retinal Tomograph II in vivo confocal microscopy in humans.核黄素-紫外线A诱导角膜胶原交联治疗进行性圆锥角膜:应用海德堡视网膜断层扫描仪II及活体共聚焦显微镜进行超微结构分析(人体研究)
Cornea. 2007 May;26(4):390-7. doi: 10.1097/ICO.0b013e318030df5a.
10
Clinical and corneal biomechanical changes after collagen cross-linking with riboflavin and UV irradiation in patients with progressive keratoconus: results after 2 years of follow-up.胶原交联联合核黄素和紫外线照射治疗进展性圆锥角膜患者的临床和角膜生物力学变化:2 年随访结果。
Cornea. 2012 Jun;31(6):609-14. doi: 10.1097/ICO.0b013e318226bf4a.

引用本文的文献

1
A Review of Keratoconus Cross-Linking Treatment Methods.圆锥角膜交联治疗方法综述
J Clin Med. 2025 Mar 3;14(5):1702. doi: 10.3390/jcm14051702.
2
Corneal scarring after epithelium-off collagen cross-linking.上皮剥脱性胶原交联术后角膜瘢痕形成
Indian J Ophthalmol. 2025 Jan 1;73(1):28-34. doi: 10.4103/IJO.IJO_95_24. Epub 2024 Sep 19.
3
Corneal Collagen Crosslinking for Ectasia After Refractive Surgery: A Systematic Review and Meta-Analysis.屈光手术后角膜扩张的角膜胶原交联:系统评价与荟萃分析
Clin Ophthalmol. 2024 Mar 19;18:865-879. doi: 10.2147/OPTH.S451232. eCollection 2024.
4
Keratoconus: A historical and prospective review.圆锥角膜:历史回顾与前瞻性展望
Oman J Ophthalmol. 2023 Oct 18;16(3):401-414. doi: 10.4103/ojo.ojo_70_23. eCollection 2023 Sep-Dec.
5
Safety and Efficacy of Corneal Cross-Linking in Patients Affected by Keratoconus: Long-Term Results.角膜交联术治疗圆锥角膜患者的安全性和疗效:长期结果。
Med Sci (Basel). 2023 Jun 16;11(2):43. doi: 10.3390/medsci11020043.
6
Evaluation of a Post-Operative Therapy Protocol after Epithelium-Off Corneal Cross-Linking in Patients Affected by Keratoconus.圆锥角膜患者上皮下角膜交联术后治疗方案的评估
J Clin Med. 2022 Nov 30;11(23):7093. doi: 10.3390/jcm11237093.
7
Topographic Outcomes in Keratoconus Surgery: Epi-on versus Epi-off Iontophoresis Corneal Collagen Cross-Linking.圆锥角膜手术的地形学结果:上皮在位与上皮去除的离子导入角膜胶原交联术对比
J Clin Med. 2022 Mar 24;11(7):1785. doi: 10.3390/jcm11071785.
8
Predictive factors of the accelerated transepithelial corneal cross-linking outcomes in keratoconus.圆锥角膜经上皮角膜交联术治疗效果的预测因素。
BMC Ophthalmol. 2022 Jan 3;22(1):7. doi: 10.1186/s12886-021-02235-4.
9
Intraocular lens power calculation changes before and after isotonic collagen cross-linking in keratoconus patients.交联术后圆锥角膜患者眼内晶状体屈光力的计算变化。
Indian J Ophthalmol. 2022 Jan;70(1):114-117. doi: 10.4103/ijo.IJO_395_21.
10
Corneal Cross-Linking: The Evolution of Treatment for Corneal Diseases.角膜交联:角膜疾病治疗的演进
Front Pharmacol. 2021 Jul 19;12:686630. doi: 10.3389/fphar.2021.686630. eCollection 2021.